Long-term results of pediatric liver transplantation in a combined pediatric and adult transplant program

CMAJ. Canadian Medical Association Journal

Volumn 166, Issue 13, 2002, Pages 1663-1671

  Atkison, Paul R ^a   Ross, B Catherine ^a   Williams, Sandy ^a   Howard, John ^a   Sommerauer, John ^a   Quan, Douglas ^a   Wall, William ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CYCLOSPORIN; GANCICLOVIR; HERPES ZOSTER IMMUNOGLOBULIN; LYMPHOCYTE ANTIBODY; OKT 3; STEROID; TACROLIMUS;

ADOLESCENT; ADULT; ARTERY THROMBOSIS; ARTICLE; BILE DUCT ATRESIA; BILE DUCT OBSTRUCTION; CHILD; CHILD GROWTH; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HEPATIC ARTERY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INFECTION; INTERVIEW; INTESTINE OBSTRUCTION; KIDNEY FUNCTION; LIVER TRANSPLANTATION; LUNG EDEMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; ORGAN DONOR; PEDIATRIC SURGERY; PERIOPERATIVE PERIOD; PLEURA EFFUSION; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; QUESTIONNAIRE; RECIPIENT; REOPERATION; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL; TELEPHONE; TREATMENT OUTCOME;

EID: 0036083983     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Liver transplantation in pediatrics: Indications, contraindications, and pretransplant management
2. Liver transplantation and its long-term management in children
3. Transplantation for childhood liver disease: An overview
4. Liver transplantation: The initial experience of a Canadian Centre
5. Liver transplantation: The University Hospital - Children's Hospital of Western Ontario experience
6. Improvement in true glomerular filtration rate after cyclosporine fractionation in pediatric liver transplant recipients
7. Cyclosporine kinetics in pediatric liver transplant recipients: Impact of dose fractionation on true glomerular filtration rate
8. Measurement of glomerular filtration rate: Single injection plasma clearance method without urine collection
9. The impairment of true glomerular filtration rate in long-term cyclosporine-treated pediatric allograft recipients
10. OKT3 as prophylaxis immunosuppression in pediatric liver transplant recipients
11. 100 Consecutive liver transplants in infants and children: An 8-year experience
12. Liver transplantation and its long-term management in children
13. Liver transplantation in 100 children: Cambridge and King's College Hospital series
14. Pediatric liver transplantation. History, recent innovations, and outlook for the future
15. One thousand liver transplants. The lessons learned
16. Risk factors and outcomes after pediatric liver transplantation
17. Long-term results of pediatric liver transplantation
18. Pediatric liver transplantation
19. Liver transplantation in children: Long-term outcome and quality of life
20. Pediatric liver transplantation with cadaveric or living related donors: Comparative results in 90 elective recipients of primary grafts
21. Long-term survival expectancy after liver transplantation in children
22. Prognostic factors for long-term actual patient survival after orthotopic liver transplantation in children
23. Factors affecting survival after orthotopic liver transplantation in infants
24. Sequential treatment of biliary atresia with Kasai portoenterostomy and liver transplantation: A review
25. Infant pediatric liver transplantation results equal those for older pediatric patients
26. Risk factors for liver rejection: Evidence to suggest enhanced allograft tolerance in infancy
27. Survival, growth and quality of life in children after orthotopic liver transplantation: A 5 year experience
28. Pediatric renal transplantation: A review of the UNOS data
29. Renal transplantation in children from 1987-1996: The 1996 annual report of the North American pediatric renal transplant cooperative study
30. Mental and motor development, social competence, and growth one year after successful pediatric liver transplantation
31. Long-term nutritional and neurodevelopmental outcome in liver transplantation in infants aged less than 12 months
32. Neuropsychological outcome of pediatric liver transplantation
33. Children's psychological health status - The impact of liver transplantation: A review
34. Cognitive patterns in school-age children with end-stage liver disease
35. Cognitive development and learning in the pediatric organ transplant recipient
36. Liver transplantation in children less than 1 year of age
37. Successful liver transplantation in babies under 1 year
38. Portal vein complications after liver transplantation for biliary atresia
39. Low-dose aspirin therapy is associated with few side effects but does not prevent hepatic artery thrombosis in liver transplant recipients
40. Hepatic artery thrombosis in pediatric liver transplantation: Graft salvage after thrombectomy
41. Late-onset acute rejection in orthotopic liver transplantation - Associated risk factors and outcomes
42. Late acute rejection occurring in liver allograft recipients
43. Timing, significance, and prognosis of late acute liver allograft rejection
44. Incidence of late acute rejection and progression to chronic rejection in pediatric liver recipients
45. Non-adherence in pediatric liver transplant recipients - An assessment of risk factors and natural history
46. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestation in children
47. Epstein-Barr virus infection in 59 orthotopic liver transplant patients
48. Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: A growing concern
49. Lymphoproliferative disorders arising under immunosuppression with FK506: Initial observations in a large transplant population
50. Epstein-Barr virus serology and Epstein-Barr virus associated lymphoproliferative disorders in pediatric liver transplant patients
51. Posttransplant malignancies in pediatric organ transplant recipients
52. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation
53. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression
54. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients